Genetic polymorphisms in TNFA/TNFR2 genes and Chagas disease in a Colombian endemic population

Cytokine

Volumn 57, Issue 3, 2012, Pages 398-401

  Criado, Libeth ^a   Flórez, Oscar ^a   Martín, Javier ^b   González, Clara Isabel ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Chagas disease; Colombia; Single nucleotide polymorphisms; Trypanosoma cruzi; Tumor necrosis factor alfa

Indexed keywords

GENOMIC DNA; PARASITE ANTIGEN;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CHAGAS DISEASE; COLOMBIA; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR ALPHA GENE; TUMOR NECROSIS FACTOR RECEPTOR 2 GENE;

CHAGAS DISEASE; COLOMBIA; ENDEMIC DISEASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

TRYPANOSOMA CRUZI;

EID: 84856377294     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.12.007     Document Type: Article

References (59)

1. Report of the Expert Committee on the control of Chagas' disease 2007, WHO, World Health Organization, (pp. 11-12).
2. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003, 98:577-591.
3. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 2002, 81:123-132.
4. Dutra W.O., Menezes C.A., Villani F.N., da Costa G.C., da Silveira A.B., Reis D., et al. Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz 2009, 104(1):208-218.
5. Nieto A., Beraun Y., Collado M.D., Caballero A., Alonso A., Gonzalez A., et al. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000, 55:195-198.
6. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol 2000, 61:320-325.
7. Drigo S.A., Cunha-Neto E., Ianni B., Cardoso M.R., Braga P.E., Fae K.C., et al. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 2006, 8:598-603.
8. Costa G.C., da Costa Rocha M.O., Moreira P.R., Menezes C.A., Silva M.R., Gollob K.J., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009, 199:451-454.
9. Florez O., Zafra G., Morillo C., Martin J., Gonzalez C.I. Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Hum Immunol 2006, 67:741-748.
10. Zafra G., Morillo C., Martin J., Gonzalez A., Gonzalez C.I. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 2007, 9:1049-1052.
11. Torres O.A., Calzada J.E., Beraun Y., Morillo C.A., Gonzalez C.I., Gonzalez A., et al. Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Hum Immunol 2009, 70:543-546.
12. Calzada J.E., Beraun Y., Gonzalez C.I., Martin J. Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine 2009, 45:149-153.
13. Torres O.A., Calzada J.E., Beraun Y., Morillo C.A., Gonzalez A., Gonzalez C.I., et al. Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol 2010.
14. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.G., et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993, 48:637-644.
15. Higuchi M.L., Benvenuti L.A., Martins R.M., Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003, 60:96-107.
16. Beraun Y., Nieto A., Collado M.D., Gonzalez A., Martin J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 1998, 52:81-83.
17. Rodriguez-Perez J.M., Cruz-Robles D., Hernandez-Pacheco G., Perez-Hernandez N., Murguia L.E., Granados J., et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 2005, 98:97-102.
18. Campelo V., Dantas R.O., Simoes R.T., Mendes-Junior C.T., Sousa S.M., Simoes A.L., et al. TNF microsatellite alleles in Brazilian Chagasic patients. Dig Dis Sci 2007, 52:3334-3339.
19. Beutler B., Van H.C. Unraveling function in the TNF ligand and receptor families. Science 1994, 264:667-668.
20. Beltinger C.P., White P.S., Maris J.M., Sulman E.P., Jensen S.J., LePaslier D., et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics 1996, 35:94-100.
21. Spies T., Morton C.C., Nedospasov S.A., Fiers W., Pious D., Strominger J.L. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986, 83:8699-8702.
22. Wilson A.G., Di Giovine F.S., Duff G.W. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995, 45:1-12.
23. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
24. Winchester E.C., Millwood I.Y., Rand L., Penny M.A., Kessling A.M. Association of the TNF-alpha-308 (G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000, 107:591-596.
25. Brinkman B.M., Huizinga T.W., Kurban S.S., van D.V., Schreuder G.M., Hazes J.M., et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?. Br J Rheumatol 1997, 36:516-521.
26. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995, 182:1259-1264.
27. Flori L., Delahaye N.F., Iraqi F.A., Hernandez-Valladares M., Fumoux F., Rihet P. TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun 2005, 6:472-480.
28. Kemper O., Derre J., Cherif D., Engelmann H., Wallach D., Berger R. The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3. Hum Genet 1991, 87:623-624.
29. Till A., Rosenstiel P., Krippner-Heidenreich A., Mascheretti-Croucher S., Croucher P.J., Schafer H., et al. The Met-196 → Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. J Biol Chem 2005, 280:5994-6004.
30. Suryaprasad A.G., Prindiville T. The biology of TNF blockade. Autoimmun Rev 2003, 2:346-357.
31. Ferraccioli G. The possible clinical application of pharmacogenetics in rheumatology. J Rheumatol 2003, 30:2517-2520.
32. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
33. Asghar T., Yoshida S., Kennedy S., Negoro K., Zhuo W., Hamana S., et al. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004, 19:2509-2514.
34. Tolusso B., Sacco S., Gremese E., La T.G., Tomietto P., Ferraccioli G.F. Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis. Hum Immunol 2004, 65:1420-1426.
35. Komata T., Tsuchiya N., Matsushita M., Hagiwara K., Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999, 53:527-533.
36. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002, 155:478-484.
37. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
38. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
39. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998, 51:605-612.
40. Tang G.J., Huang S.L., Yien H.W., Chen W.S., Chi C.W., Wu C.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736.
41. Sohail M., Kaul A., Bali P., Raziuddin M., Singh M.P., Singh O.P., et al. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients. Mol Immunol 2008, 45:1682-1692.
42. Ferreira R.C., Ianni B.M., Abel L.C., Buck P., Mady C., Kalil J., et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/" indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003, 98:407-411.
43. Talvani A., Rocha M.O., Barcelos L.S., Gomes Y.M., Ribeiro A.L., Teixeira M.M. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004, 38:943-950.
44. Drigo S.A., Cunha-Neto E., Ianni B., Mady C., Fae K.C., Buck P., et al. Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 2007, 108:109-111.
45. Gonzalez C.I., Moreno O., Saaibi D.L., Otero W., Badillo R., Martin J., et al. Polimorfismos en la región promotora del gen del TNF-alfa en artritis reumatoidea. Salud UIS 2006, 38:197-203.
46. Kumar R., Goswami R., Agarwal S., Israni N., Singh S.K., Rani R. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 2007, 69:557-567.
47. Shaw B.E., Maldonado H., Madrigal J.A., Smith C., Petronzelli F., Mayor N.P., et al. Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens 2004, 63:401-411.
48. Karplus T.M., Jeronimo S.M., Chang H., Helms B.K., Burns T.L., Murray J.C., et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 2002, 70:6919-6925.
49. Kamali-Sarvestani E., Rasouli M., Mortazavi H., Gharesi-Fard B. Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 2006, 35:159-165.
50. Clark T.G., Diakite M., Auburn S., Campino S., Fry A.E., Green A., et al. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J Infect Dis 2009, 199:569-575.
51. Vejbaesya S., Luangtrakool P., Luangtrakool K., Kalayanarooj S., Vaughn D.W., Endy T.P., et al. Allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 2009, 199:1442-1448.
52. Tan J.H., Price P., Gut I., Stacey M.C., Warrington N.M., Wallace H.J. Characterization of tumor necrosis factor - block haplotypes associated with susceptibility to chronic venous leg ulcers in Caucasian patients. Hum Immunol 2010, 71:1214-1219.
53. Moreno M., Silva E.L., Ramírez L.E., Palacio L.G., Rivera D., Arcos-Burgos M. Chagas' disease susceptibility/resistance. linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 2004, 64:18-24.
54. Kim H., Chun S., Ku S.Y., Suh C.S., Choi Y.M., Kim J.G. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Menopause 2009, 16:1014-1020.
55. Sharma S., Rathored J., Ghosh B., Sharma S.K. Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis 2010, 10:165.
56. Sato H., Silveira L., Fingerlin T., Dockstader K., Gillespie M., Lagan A.L., et al. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 2007, 119:687-696.
57. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 2001, 17:99-107.
58. Kroll-Palhares K., Silverio J.C., Silva A.A., Michailowsky V., Marino A.P., Silva N.M., et al. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem Inst Oswaldo Cruz 2008, 103:375-385.
59. Bilate A.M., Salemi V.M., Ramires F.J., de B.T., Russo M., Fonseca S.G., et al. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 2007, 9:1104-1113.